Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2014-02-14 Report Publication Anno…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Presentation of fourth quarter results and preliminary results for 2013 for Medistim ASA
Report Publication Announcement Classification · 97% confidence The document text is very short (600 chars) and explicitly states it is an 'invitation' to a 'presentation' of fourth quarter and preliminary 2013 results, including the time and location. This strongly suggests it is an announcement about an upcoming event where results will be discussed, rather than the full results document itself (like an ER or IR). Since it is an announcement related to financial results presentation, it fits best as an Investor Presentation (IP) if it were the slides, or potentially an Earnings Release (ER) if it contained the key numbers. However, given the context of inviting people to a presentation event, it functions as a notification about the presentation itself. Since there is no specific category for 'Presentation Invitation', and it is announcing the presentation of results, it is closest to an Investor Presentation (IP) or potentially an Earnings Release (ER) if the actual results were embedded. Given the focus on the *presentation* event, and the brevity, it is most likely a precursor or summary announcement. If the actual presentation slides were attached, it would be IP. If it were the press release of the numbers, it would be ER. Since it is an invitation to the presentation, it is a form of investor communication. I will classify it as an Investor Presentation (IP) as it directly relates to the material being presented to investors, even if it's just the invitation.
2014-02-14 English
Reporting dates for Medistim ASA for 2014
Report Publication Announcement Classification · 98% confidence The document text explicitly lists the 'Reporting dates' for Medistim ASA for the year 2014, detailing when the presentations for Q4 2013, Q1 2014, Q2 2014, and Q3 2014 results will occur. This is an announcement about the schedule of future financial report releases, not the reports themselves. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2014-01-10 English
Lederskifte i Medistim USA
Board/Management Information Classification · 100% confidence The document text is very short (293 characters) and announces a change in leadership within Medistim USA, specifically the resignation of the President and the appointment of an interim replacement. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2014-01-07 Norwegian
Change of leadership in Medistim USA
Board/Management Information Classification · 100% confidence The document text explicitly announces a change in leadership within Medistim USA, stating that the President, Howie Milstein, is leaving and naming an interim replacement (Mike Farbelow). This directly corresponds to the definition of Board/Management Information.
2014-01-07 English
MEDISTIM ANNOUNCES THAT FDA HAS INSPECTED THEIR FACILITY IN OSLO AND HORTEN
Regulatory Filings Classification · 95% confidence The document is a press release announcing the successful completion of an FDA inspection of the company's facilities. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a regulatory disclosure regarding company operations and compliance, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for general corporate announcements.
2011-01-28 English
MEDISTIM KUNNGJØR AT FDA HAR HATT EN INSPEKSJON AV SELSKAPETS VIRKSOMHET I OSLO OG HORTEN
Regulatory Filings Classification · 95% confidence The document is a press release from MediStim announcing the results of an FDA inspection of their facilities. It is a regulatory announcement regarding company operations and compliance, which does not fit into specific financial reporting categories like 10-K or IR. As it is a general regulatory announcement required by the Norwegian Securities Trading Act, it falls under the RNS (Regulatory Filings) category.
2011-01-28 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.